Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.

MUTUALPHARM : revenue, balance sheet and financial ratios

MUTUALPHARM is a French company founded 16 years ago, specialized in the sector Conseil pour les affaires et autres conseils de gestion. Based in ECULLY (69130), this company of category PME shows in 2020 a net income positive of 238 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-04-25

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - MUTUALPHARM (SIREN 519285019)
Indicator 2020 2019 2018 2017
Revenue N/C N/C N/C N/C
Net income 237 531 € 197 219 € 271 839 € 254 336 €
EBITDA N/C N/C N/C N/C
Net margin N/C N/C N/C N/C

Revenue and income statement

In 2020, MUTUALPHARM generates positive net income of 238 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2020: 254 k€ -> 238 k€.

Net income (2020) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

237 531 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 4%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 88%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2020) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

4.334%

Financial autonomy (2020) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

88.113%

Asset age ratio (2020) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

58.7%

Solvency indicators evolution
MUTUALPHARM

Sector positioning

Debt ratio
4.33 2020
2018
2019
2020
Q1: 0.0
Med: 5.56
Q3: 57.97
Good -6 pts over 3 years

In 2020, the debt ratio of MUTUALPHARM (4.33) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
88.11% 2020
2018
2019
2020
Q1: 5.51%
Med: 38.11%
Q3: 73.12%
Excellent

In 2020, the financial autonomy of MUTUALPHARM (88.1%) ranks in the top 25% of the sector. This ratio represents the share of equity in total financing. High autonomy reflects financial independence and ability to absorb shocks.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 1166.61. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2020) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

1166.609

Liquidity indicators evolution
MUTUALPHARM

Sector positioning

Liquidity ratio
1166.61 2020
2018
2019
2020
Q1: 139.95
Med: 286.59
Q3: 705.54
Excellent

In 2020, the liquidity ratio of MUTUALPHARM (1166.61) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.

Positioning of MUTUALPHARM in its sector

Comparison with sector Conseil pour les affaires et autres conseils de gestion

Valuation estimate

Based on 53 transactions of similar company sales in 2020, the value of MUTUALPHARM is estimated at 1 025 583 € (range 348 696€ - 2 897 363€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2020
53 tx
348k€ 1025k€ 2897k€
1 025 583 € Range: 348 696€ - 2 897 363€
NAF 5 année 2020

Valuation method used

Net Income Multiple
237 531 € × 4.3x = 1 025 584 €
Range: 348 696€ - 2 897 364€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 53 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Conseil pour les affaires et autres conseils de gestion)

Compare MUTUALPHARM with other companies in the same sector:

Voir toutes les statistiques du secteur Conseil pour les affaires et autres conseils de gestion

Frequently asked questions about MUTUALPHARM

What is the revenue of MUTUALPHARM ?

The revenue of MUTUALPHARM is not publicly disclosed (confidential accounts filed with INPI).

Is MUTUALPHARM profitable?

Yes, MUTUALPHARM generated a net profit of 238 k€ in 2020.

Where is the headquarters of MUTUALPHARM ?

The headquarters of MUTUALPHARM is located in ECULLY (69130), in the department Rhone.

Where to find the tax return of MUTUALPHARM ?

The tax return of MUTUALPHARM is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does MUTUALPHARM operate?

MUTUALPHARM operates in the sector Conseil pour les affaires et autres conseils de gestion (NAF code 70.22Z). See the 'Sector positioning' section above to compare the company with its competitors.